Press Releases from Visongain Limited (4 total)
Visiongain publishes Clinical Trials Materials Storage and Distribution Market R …
Visiongain has launched a new report Clinical Trials Materials Storage and Distribution Market Report 2020-2030: Forecasts by Type (Cold Chain, Non-Cold Chain), Product (Pharmaceutical, Diagnostic), and Medical Specialty (Oncology, Cardiology, and Immunology). PLUS, Major Developments in the Market PLUS COVID-19 Impact Analysis.
The global Clinical Trials Materials Storage and Distribution market for pharma is estimated to have reach $xxxmn in 2020, dominated by the clinical trial manufacturing segment. The global Clinical…
Allergic Rhinitis Drugs market affected by Covid-19
Visiongain has launched a new pharma report Allergic Rhinitis Drugs Market Report 2020-2030: Forecasts by Sub-Markets (Intranasal Antihistamines, Intranasal Corticosteroids, Oral Antihistamines, Immunotherapy and Vaccines, Others), Intranasal Antihistamines (Dymista, Generic Intranasal Azelastine, Astepro, Patanase, Astelin, Others), Intranasal Corticosteroids (Flixonase/Flonase/Flonase OTC, Nasonex, Avamys/Veramyst, Rhinocort, Nasacort/Nasacort-OTC, Omnaris, Beconase/Beconaes AQ, Qnasl, Zetonna, Others), Oral Antihistamines (Allegra/Allegra-D/Allegra OTC, Claritin/Claritin OTC, Zyrtec/Zyrtec D, Xyzal, Clarinex, Allelock, Ebastel, Talion, Others), Immunotherapy and Vaccines (Staloral, Alutard SQ,…
Visiongain provides insight on The Global Respiratory Inhalers Market 2018-2028.
The Global Respiratory Inhalers Market 2018-2028: Dry Powder Inhalers, Single-dose DPI, Multi-dose DPI, Metered Dose Inhalers, Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers, Asthma, COPD, Others
Respiratory inhalers are used to relieve the symptoms of asthma and COPD and prevent exacerbations, which can lead to expensive hospital stays for patients and increase the risk of mortality. The increase in emission of air pollutants due to economic and industrial growth has made…
Visiongain’ has launched a new pharma report: Global Next-Generation Antibody …
Visiongain’ has launched a new pharma report: Global Next-Generation Antibody Therapies Market Forecast 2018-2028: Antibody-Drug Conjugates, Engineered Antibodies, Bispecific Antibodies, Antibody Fragments & ALPs, Biosimilar Antibodies
Next-generation antibody therapies are becoming established treatments for haematological malignancies and solid tumours. (phase 3) pipelines are relatively sparse, however, with most pipeline candidates in phase 1 or phase 2 of development. Growth will be rapid from the middle of the forecast period as…
